FDA Orange Book · active-ingredient family
Technetium tc-99m tilmanocept
Technetium tc-99m tilmanocept is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:LYMPHOSEEK KIT · NDA 202207
1
Brand (NDA)
0
Generics (ANDA)
1
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| LYMPHOSEEK KITRLD | CARDINAL HEALTH 414 | NDA 202207 | — | Mar 13, 2013 |
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9439985 | Jan 30, 2029 | in 2 yr 8 mo | Product |
Technetium tc-99m tilmanocept — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

